It should be borne in mind that TOP1 inhibitors and other drugs can cause anomalous increases in CMV reporter-controlled expression of luciferase and GFP, potentially confounding the interpretation of tumor imaging studies and pre-clinical drug testing. The gene discussed is TOP1; the disease is neoplasm.